ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking

Area of Science:

• Cell Biology
• Molecular Biology
• Protein Interactions

Background:

• ADP-ribosylation factor (Arf)-directed GTPase-activating protein (GAP) ARAP1 inhibits epidermal growth factor receptor (EGFR) trafficking to early endosomes.
• Understanding ARAP1's function necessitates identifying its interacting partners.

Purpose of the Study:

• To identify proteins that interact with ARAP1.
• To elucidate the role of ARAP1-protein interactions in EGFR trafficking and ubiquitination.

Main Methods:

• Co-immunoprecipitation assays to identify ARAP1 interacting proteins.
• Site-directed mutagenesis to determine key interaction domains (ARAP1 Arg86/Arg90, CIN85 SH3 domains).
• Analysis of EGFR trafficking, ubiquitination, and degradation in response to altered ARAP1 and CIN85 expression levels.

Main Results:

• ARAP1 directly associates with Cbl-interacting protein of 85 kDa (CIN85).
• Specific arginine residues in ARAP1 and Src homology 3 domains in CIN85 are crucial for this interaction.
• Reduced ARAP1 or CIN85 expression impairs EGFR trafficking to early endosomes.
• ARAP1 overexpression reduces EGFR ubiquitination by Cbl and slows EGFR degradation; conversely, reduced ARAP1 expression accelerates degradation.

Conclusions:

• The ARAP1-CIN85 interaction is critical for regulating EGFR endocytic trafficking.
• This complex influences EGFR ubiquitination and degradation.
• A proposed model suggests the ARAP1-CIN85 complex directs the EGF-EGFR-Cbl complex into a non-canonical endosomal pathway.